Literature DB >> 30113776

[Acute respiratory distress revealing antisynthetase syndrome].

Q Maloir1, K Ghysen1, C von Frenckell2, R Louis1, J Guiot3.   

Abstract

Antisynthetase syndrome is a clinical entity characterized by specific anti-aminoacyl-tRNA-synthetase antibodies usually associated with inflammatory myopathy and interstitial lung disease. The classic presentation of the pathology is the pulmonary interstitium involvment, wich commonly determines the global prognosis. The subsequent diagnosis of antisynthetase syndrome in patients with acute respiratory distress syndrome (ARDS) is unusual, even more so when a veino-veinous (VV) extracorporeal membrane oxygenation (ECMO) is required. This article presents a clinical case of antisynthetase syndrome with severe ARDS successfully treated with immunosuppressive agents and ECMO.

Entities:  

Keywords:  ARDS ; ECMO; Interstitial lung disease ; JO1 ; Myositis ; Antisynthetase

Mesh:

Year:  2018        PMID: 30113776

Source DB:  PubMed          Journal:  Rev Med Liege        ISSN: 0370-629X


  18 in total

1.  [Analysis of the correlation between lymphocyte subsets and severity of corona virus disease 19].

Authors:  F Bao; W L Shi; J Hu; D Zhang; D H Gao; Y X Xia; H M Jing; X Y Ke; Q G Ge; N Shen
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

2.  Physical Activity and Natural Products and Minerals in the SARS-CoV-2 Pandemic: An Update.

Authors:  Ayoub Saeidi; Seyed Morteza Tayebi; Oam To-Aj; Niloofar Karimi; Sahar Kamankesh; Saber Niazi; Abedin Khosravi; Mitra Khademosharie; Mohammad Soltani; Kelly E Johnson; Harunor Rashid; Ismail Laher; Anthony C Hackney; Hassane Zouhal
Journal:  Ann Appl Sport Sci       Date:  2021

3.  Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus.

Authors:  Dafeng Liu; Lijuan Lan; Dongxia Luo; Bennan Zhao; Guo Wei; Yinsheng He; Renqing Zhang; Yaling Liu
Journal:  Diabetes Res Clin Pract       Date:  2020-07-22       Impact factor: 5.602

4.  Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis.

Authors:  Jens Devogelaere; Marie B D'hooghe; Famke Vanderhauwaert; Miguel D'haeseleer
Journal:  Neurol Sci       Date:  2020-06-20       Impact factor: 3.307

Review 5.  COVID-19: A promising cure for the global panic.

Authors:  Balachandar Vellingiri; Kaavya Jayaramayya; Mahalaxmi Iyer; Arul Narayanasamy; Vivekanandhan Govindasamy; Bupesh Giridharan; Singaravelu Ganesan; Anila Venugopal; Dhivya Venkatesan; Harsha Ganesan; Kamarajan Rajagopalan; Pattanathu K S M Rahman; Ssang-Goo Cho; Nachimuthu Senthil Kumar; Mohana Devi Subramaniam
Journal:  Sci Total Environ       Date:  2020-04-04       Impact factor: 7.963

6.  Is a healthy microbiome responsible for lower mortality in COVID-19?

Authors:  Lubomír Janda; Matúš Mihalčin; Michaela Šťastná
Journal:  Biologia (Bratisl)       Date:  2020-10-15       Impact factor: 1.350

7.  The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2.

Authors:  Wael Alturaiki; Ayman Mubarak; Abduallah Al Jurayyan; Maged Gomaa Hemida
Journal:  Hum Vaccin Immunother       Date:  2021-06-11       Impact factor: 3.452

8.  Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities.

Authors:  Ahmed Yaqinuddin
Journal:  Med Hypotheses       Date:  2020-06-30       Impact factor: 1.538

Review 9.  A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants.

Authors:  Johnson O Oladele; Ebenezer I Ajayi; Oyedotun M Oyeleke; Oluwaseun T Oladele; Boyede D Olowookere; Boluwaji M Adeniyi; Olu I Oyewole; Adenike T Oladiji
Journal:  Heliyon       Date:  2020-09-09

Review 10.  Gastrointestinal and renal complications in SARS-CoV-2-infected patients: Role of immune system.

Authors:  Fatemeh Maghool; Ali Valiani; Tahereh Safari; Mohammad Hassan Emami; Samane Mohammadzadeh
Journal:  Scand J Immunol       Date:  2020-12-07       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.